BIOMAT Database Logo BIOMAT Database Logo

Hepatitis B immune serum globulin in prevention of nonparenterally transmitted hepatitis B. 1974

W Szmuness, and A M Prince, and M Goodman, and C Ehrich, and R Pick, and M Ansari

UI MeSH Term Description Entries
D007116 Immunization, Passive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D008297 Male Males
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002674 Child, Institutionalized A child who is receiving long-term in-patient services or who resides in an institutional setting. Institutionalized Child,Children, Institutionalized,Institutionalized Children
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D005719 gamma-Globulins Serum globulins that migrate to the gamma region (most positively charged) upon ELECTROPHORESIS. At one time, gamma-globulins came to be used as a synonym for immunoglobulins since most immunoglobulins are gamma globulins and conversely most gamma globulins are immunoglobulins. But since some immunoglobulins exhibit an alpha or beta electrophoretic mobility, that usage is in decline. gamma-Globulin,gamma Globulin,gamma Globulins

Related Publications

W Szmuness, and A M Prince, and M Goodman, and C Ehrich, and R Pick, and M Ansari
Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine.
November 1983, Lancet (London, England),
W Szmuness, and A M Prince, and M Goodman, and C Ehrich, and R Pick, and M Ansari
Hepatitis B immune globulin and immune serum globulin.
August 1980, The New England journal of medicine,
W Szmuness, and A M Prince, and M Goodman, and C Ehrich, and R Pick, and M Ansari
[Hepatitis B immune serum globulin].
August 2004, Nihon rinsho. Japanese journal of clinical medicine,
W Szmuness, and A M Prince, and M Goodman, and C Ehrich, and R Pick, and M Ansari
[Hepatitis B immune serum globulin].
October 1995, Nihon rinsho. Japanese journal of clinical medicine,
W Szmuness, and A M Prince, and M Goodman, and C Ehrich, and R Pick, and M Ansari
Prevention of hepatitis type B with specific immune serum globulin.
January 1976, Nephron,
W Szmuness, and A M Prince, and M Goodman, and C Ehrich, and R Pick, and M Ansari
Hepatitis B prevention strategies: a benefit-cost analysis of immune serum globulin, hepatitis B immune globulin, and hepatitis B vaccine in the military.
January 1986, American journal of preventive medicine,
W Szmuness, and A M Prince, and M Goodman, and C Ehrich, and R Pick, and M Ansari
Viral hepatitis, type B (MS-2 strain) prevention with specific hepatitis B immune serum globulin.
December 1971, JAMA,
W Szmuness, and A M Prince, and M Goodman, and C Ehrich, and R Pick, and M Ansari
Review: hepatitis B immune globulin for prevention of hepatitis B infection.
July 2007, Journal of medical virology,
W Szmuness, and A M Prince, and M Goodman, and C Ehrich, and R Pick, and M Ansari
Immune serum globulin for prevention of viral hepatitis.
May 1969, Delaware medical journal,
W Szmuness, and A M Prince, and M Goodman, and C Ehrich, and R Pick, and M Ansari
Letter: Prevention of hepatitis B with "immune" globulin.
March 1976, The New England journal of medicine,
Copied contents to your clipboard!